| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2000334 | 重组抗CD20人源化单克隆抗体皮下注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-11-28 | 上海交联药物研发有限公司 | Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd | In Review | 2020-11-27 | view |
| CXSL1700072 | 注射用重组抗HER2人源化单克隆抗体-MCC-DM1偶联剂 | B-003 | Lyophilized | Biological Products(2) | New Drug Application | 2017-07-31 | 上海交联药物研发有限公司 | Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd | Certificate Issued | 2018-02-25 | view |